Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Health Canada approves two generic versions of Ozempic Published 9:13 am Saturday, May 2, 2026 Health Canada approved two generic versions of the brand-name drug Ozempic this week, and Canada is the first among the G7 countries to do so
It enhances the insulin response beyond what GLP-1 achieves alone, appears to improve fat metabolism pathways, may contribute to central nervous system appetite regulation through mechanisms distinct from GLP-1, and seems to reduce GLP-1 related nausea, which explains why Tirzepatide has better tolerability than Semaglutide despite being more potent
This approach simplifies the regimen to a single daily injection but limits dosing flexibility
Sites: Abdomen, thigh, or anywhere with subcutaneous fat Volume: 0.1 mL with insulin syringe (29-31 gauge) Rotation: Trial protocols describe rotating injection sites to minimize lipodystrophy risk Reconstitution Quick Reference Math: 10 mg / 2 mL = 5 mg/mL
